Corrigendum : An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection
Copyright © 2020 Ye, Wang, Liu, Ma, Dong, Yao, Wang, Zhang, Zhang, Cheng, Xu, Lei, Zhang and Ye..
[This corrects the article DOI: 10.3389/fphar.2019.01203.].
| Errataetall: |
ErratumFor: Front Pharmacol. 2019 Oct 16;10:1203. - PMID 31680975 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Frontiers in pharmacology - 11(2020) vom: 07., Seite 201 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ye, Chuantao [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
BXA |
|---|
| Anmerkungen: |
Date Revised 28.09.2020 published: Electronic-eCollection ErratumFor: Front Pharmacol. 2019 Oct 16;10:1203. - PMID 31680975 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fphar.2020.00201 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM307673847 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM307673847 | ||
| 003 | DE-627 | ||
| 005 | 20231225130059.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fphar.2020.00201 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1025.xml |
| 035 | |a (DE-627)NLM307673847 | ||
| 035 | |a (NLM)32180732 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ye, Chuantao |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum |b An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.09.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ErratumFor: Front Pharmacol. 2019 Oct 16;10:1203. - PMID 31680975 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2020 Ye, Wang, Liu, Ma, Dong, Yao, Wang, Zhang, Zhang, Cheng, Xu, Lei, Zhang and Ye. | ||
| 520 | |a [This corrects the article DOI: 10.3389/fphar.2019.01203.] | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Published Erratum | |
| 650 | 4 | |a BXA | |
| 650 | 4 | |a FFA | |
| 650 | 4 | |a T-705 | |
| 650 | 4 | |a hantavirus | |
| 650 | 4 | |a viral nucleic acid synthesis inhibitors | |
| 700 | 1 | |a Wang, Dan |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, He |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Hongwei |e verfasserin |4 aut | |
| 700 | 1 | |a Dong, Yangchao |e verfasserin |4 aut | |
| 700 | 1 | |a Yao, Min |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yuan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Hui |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Liang |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Linfeng |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Zhikai |e verfasserin |4 aut | |
| 700 | 1 | |a Lei, Yingfeng |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Fanglin |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Wei |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in pharmacology |d 2010 |g 11(2020) vom: 07., Seite 201 |w (DE-627)NLM208568891 |x 1663-9812 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2020 |g day:07 |g pages:201 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fphar.2020.00201 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2020 |b 07 |h 201 | ||